openPR Logo
Press release

Postpartum Hemorrhage (PPH) Treatment Devices Market: Increasing Prevalence of Obesity and Hypertension among Women to Drive Demand

12-12-2016 01:43 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Postpartum Hemorrhage (PPH) Treatment Devices Market:

The global postpartum hemorrhage (PPH) treatment devices market is fragmented. Some of the strategies employed by players in the market are expansion of product portfolio and distribution network. Companies are competing with each other in terms of making the treatment devices affordable. However, the global postpartum hemorrhage (PPH) treatment market is expected to witness a high level threat of substitutes from pharmaceutical and surgical interventions, which are being preferred owing to a lack of awareness and reluctance to accept PPH treatment devices, especially in developing nations. New entrants, in order to sustain in the market have to make significant investments for establishment of their brands. New players have to face several barriers such as strong distribution requirement, compliance with stringent regulations, and cost competition, states a new report by Transparency Market Research (TMR). However, companies can enter the market by means of mergers and acquisitions. Overall, the threat of new entrants is expected to be moderate.

According to the report, the global postpartum hemorrhage (PPH) treatment devices market is expected to rise from US$604.4 mn in 2014 to US$926.1 mn by 2023. On the basis of product, the uterine balloon tamponade market is expected to lead and be worth US$279.6 mn by 2023. This segment is also expected to witness a high CAGR of 5.3% from 2015 to 2023. On the basis of geography, Asia Pacific is expected to expand at a fast CAGR of 6.3% from 2015 to 2023. North America led in the past and is expected to lead in the coming years. North America is expected to be worth US$310.7 mn.

Get Sample Research Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164

Awareness Campaigns and Government Initiatives to Create Awareness Driving Market

According to the systemic analysis report published in the Lancet in 2010, more than 350,000 women die from pregnancy-related complications and during childbirth across the world. A lack of skilled healthcare providers and inadequate communication and transportation systems are increasing the prevalence of postpartum hemorrhage, which is the loss of 500 ml blood or more. The growing awareness campaigns conducted by global non-profit organizations as well as educational and training programs by government will also drive the market for postpartum hemorrhage treatment devices.

The growing prevalence of obesity is increasing the risk of postpartum hemorrhage and this is also expected to fuel the demand for PPH treatment devices. In addition to this, many women are suffering from hypertension, which again increases the risk of PPH. Thus, the demand for postpartum hemorrhage treatment devices is expected to rise in the coming years as more and more women suffer from obstetric hemorrhage.

Low Acceptance of Unconventional Postpartum Hemorrhage Preventive Devices

Today, surgical interventions and drug therapies have become popular for the prevention of deaths occurring due to postpartum hemorrhage. To support this, there are several clinical studies that illustrate the safety and efficiency of these treatment methods. This is leading to a gradual decrease in the acceptance of postpartum hemorrhage treatment devices. Low awareness among people regarding PPH treatment devices is another key factor hampering the market. The awareness is particularly low in the developing nations of Asia Pacific, the Middle East and Africa. However, players in the market are focusing on enhancing their distribution channels and awareness in these countries and this is expected to emerge as a growth opportunity.

Browse Full Research Report and TOC:
http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html

This information is based on the findings of a report published by Transparency Market Research titled “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023.”

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postpartum Hemorrhage (PPH) Treatment Devices Market: Increasing Prevalence of Obesity and Hypertension among Women to Drive Demand here

News-ID: 394107 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for PPH

Global Postpartum Hemorrhage (PPH) Devices Market Research Report 2023-2029
Postpartum Hemorrhage (PPH) Devices report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Postpartum Hemorrhage (PPH) Devices market is projected to reach US$ 791.7 million in 2029, increasing from US$ 593.3 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Demand from Hospital and Conservation Station are the major drivers for the industry. Global Postpartum Hemorrhage (PPH)
Postpartum Hemorrhage (PPH) Devices Market Sluggish Growth Rate Projected 2023-2 …
Postpartum Hemorrhage (PPH) Devices Market is expected to witness moderate growth registering 6.2% CAGR during the forecast period (2023-2029). By observing alternative approaches, this Postpartum Hemorrhage (PPH) Devices Market research report aims to analyze the sales force for product distribution. It helps key players reduce investment risk by providing relevant data and business considerations. Key organizations can easily get a clear view of current market conditions and ideas to make their
07-01-2020 | Sports
iBet
PayPerHead.net launches PPH review site
New Industry reviewing portal will encompass all PPH companies and assess the benefits of each PPH software service. 29.06.2020 – San Jose, Costa Rica PayPerHead.net – the advanced pay per head bookie service supporting industry growth at all levels – has announced its launch of a review site which will compare the features and benefits of all pay per head (PPH) providers on the market. The new review platform will seek to break
Polypropylene Homopolymer (PPH) Resin Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Polypropylene Homopolymer (PPH) Resin market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Polypropylene Homopolymer (PPH) Resin market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Polypropylene Homopolymer (PPH) Resin market,
PPH Devices Market : The Next Big Thing in Medical Device Industry
Post-partum Hemorrhage (PPH) Devices Market Report, published by Allied Market Research, was valued at $637 million in 2015, and is expected to garner $906 million by 2022, registering a CAGR of 5.2% during the period 2016 - 2022.The Uterine balloon tamponade is expected to remain the highest revenue-generating segment throughout the forecast period. Download Request Sample Copy: https://www.alliedmarketresearch.com/request-sample/1676 The factors that are expected to drive the growth of the PPH market are:
Global Postpartum Hemorrhage (PPH) Treatment Devices Market is Primarily being D …
The global postpartum hemorrhage treatment devices market is progressing at a CAGR of 4.9% within a forecast period of 2015 to 2023. Owing to this positive growth rate, the market is expected to reach US$926.1 mn before the end of 2023. The global postpartum hemorrhage treatment devices market was recorded at US$604.4 mn in 2014, according to a research report released by Transparency Market Research. The report, titled “Postpartum Hemorrhage